Fulphila |
pegfilgrastim-jmdp
|
01/01/2019 |
- Requires Excluded Exception Approval
- Subject to Quantity Limits
|
Neutropenia |
Fusilev |
Levoleucovorin
|
01/01/2017 |
|
Oncology |
Fuzeon |
enfuvirtide
|
01/01/2018 |
- Subject to Quantity Limits
|
HIV |
Galafold |
migalastat
|
01/01/2019 |
|
Lysosomal Storage Disorders |
GamaSTAN S/D |
immune globulin (Human)
|
01/01/2019 |
- Requires Excluded Exception Approval
|
IVIG |
Gamifant |
emapalumab-Izsg
|
04/01/2019 |
|
Blood Disorders |
Gammaguard |
Immune globulin
|
01/01/2017 |
|
IVIG |
Gammaked |
immune globulin injection (Human)
|
01/01/2017 |
|
IVIG |
Gammunex-C |
Immune globulin
|
01/01/2017 |
|
IVIG |
Ganirelix acetate |
ganirelix acetate
|
01/01/2017 |
|
Fertility Products - Specialty |
Gattex |
Teduglutide
|
01/01/2017 |
|
GI Disorders |
Gazyva |
Obinutuzumab
|
01/01/2017 |
|
Oncology |
Gel-One |
hyaluronate
|
01/01/2017 |
|
Osteoarthritis |
Gelsyn-3 |
hyaluronate
|
01/01/2017 |
|
Osteoarthritis |
Gemzar |
gemcitabine
|
12/01/2020 |
|
Oncology |
Genotropin |
somatropin
|
01/01/2017 |
- Requires Excluded Exception Approval
|
Growth Hormone and Related Disorders |
Genvisc 850 |
hyaluronate
|
01/01/2017 |
|
Osteoarthritis |
Genvoya |
elvitegravir/cobicistat/emtricitabine/tenofovir
|
01/01/2018 |
- Subject to Quantity Limits
|
HIV |
Gilenya |
fingolimod capsules
|
01/01/2018 |
|
Multiple Sclerosis |
Gilotrif |
afatinib
|
01/01/2018 |
|
Oncology |
Glassia |
Alpha-1-proteinase Inhibitor
|
01/01/2017 |
|
Alpha-1 Antitrypsin Deficiency |
Glatopa |
glatiramer acetate injection
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Multiple Sclerosis |
Gleevec |
imatinib mesylate
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Oncology |
Glumetza |
metformin ER
|
08/01/2017 |
|
Diabetes |
Gonal-F |
follitropin alfa
|
01/01/2017 |
|
Fertility Products - Specialty |
Granix |
Tbo-Filgrastim
|
01/01/2017 |
|
Neutropenia |
Grastek |
timothy grass pollen allergen extract sublingual [SL] tablets
|
01/01/2017 |
|
Sublingual Immunotherapy Products |
H.P. Acthar Gel |
repository corticotropin injection
|
08/01/2017 |
|
Seizure Disorders |
Haegarda |
C1 Esterase Inhibitor
|
01/01/2018 |
|
Hereditary Angioedema |
Halaven |
Eribulin
|
01/01/2017 |
|
Oncology |
Halcion |
Triazolam
|
01/01/2017 |
- Subject to Quantity Limits
|
Sedative-Hypnotics |
Halog (Brand Only) |
halcinonide
|
01/01/2019 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Corticosteroid |
Harvoni |
sofosbuvir/ledipasvir tablets
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Hepatitis C |
Helixate FS |
Antihemophilic factor VIII
|
01/01/2017 |
- Requires Excluded Exception Approval
|
Hemophilia |
Hemlibra |
emicizumab-kxwh
|
01/01/2018 |
- Requires Excluded Exception Approval
|
Hemophilia |
Hemofil M |
Antihemophilic factor VIII
|
01/01/2017 |
|
Hemophilia |
Herceptin |
Trastuzumab
|
01/01/2017 |
|
Oncology |
Herceptin Hylecta |
Trastuzumab and hyaluronidase-oysk
|
01/01/2017 |
|
Oncology |
Heruzuma |
trastuzumab-pkrb
|
07/01/2020 |
|
Oncology |
Hetlioz |
tasimelteon capsules
|
01/01/2018 |
|
Sleep Disorders |
Hizentra |
immune globulin subcutaneous
|
01/01/2017 |
|
IVIG |
Humate-P |
Antihemophilic Factor VIII
|
10/01/2017 |
|
Hemophilia |
Humatrope |
somatropin injection
|
01/01/2017 |
|
Growth Hormone and Related Disorders |
Humira |
adalimumab injection
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
IBS/RA/Psoriasis |
Hyalgan |
Sodium Hyaluronate
|
01/01/2017 |
- Requires Excluded Exception Approval
|
Osteoarthritis |
Hyaluronates |
|
01/01/2020 |
|
Osteoarthritis |
Hycamtin |
Topotecan
|
01/01/2017 |
|
Oncology |
Hymovis |
Sodium Hyaluronate
|
01/01/2017 |
- Requires Excluded Exception Approval
|
Osteoarthritis |
HyQvia |
immune globulin subcutaneous
|
01/01/2018 |
|
IVIG |
Hysingla |
hydrocodone bitartrate extended-release tablets
|
03/01/2017 |
- Requires Prior Approval
- Requires Step Therapy
- Subject to Quantity Limits
|
Opioid Analgesics - Extended-Release |